GD3, a ganglioside expressed on human melanoma, can be recognized by the humoral immune system. In this paper, we demonstrate that immunizing mice with the human melanoma cell line SK-MEL-28 (GD3+ GM2− CD1−) or with syngeneic APCs loaded with GD3 can induce a GD3-reactive natural killer T (NKT) cell response. GD3-reactive NKT cells were detected among splenocytes of immunized mice at frequencies of ∼1:2,000 both by ELISPOT and GD3-loaded mouse CD1d tetramer analysis. GD3-reactive NKT cells did not react with GM2, a closely related ganglioside, and were not detectable in unimmunized mice. GD3-reactive NKT cells initially produced IL-4 and IFN-γ followed by IL-10. They were CD1d restricted in that reactivity was abrogated when APCs were blocked with anti-CD1d monoclonal antibody before being loaded with GD3 or when APCs from CD1d knockout mice were used. Because SK-MEL-28 does not express any isoform of human CD1, GD3 must be cross-presented by murine APCs in vivo. This is the first analysis of a natural ligand for mouse NKT cells and the first definitive paper of cross-presentation to NKT cells. This could be a mechanism for NKT cell recognition of tumor gangliosides in CD1− tumors.
Skip Nav Destination
Article navigation
7 July 2003
Article Contents
Article|
July 07 2003
Cross-presentation of Disialoganglioside GD3 to Natural Killer T Cells
Dianna Y. Wu,
Dianna Y. Wu
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021
2Swim Across America Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY 10021
Search for other works by this author on:
Neil H. Segal,
Neil H. Segal
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021
2Swim Across America Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY 10021
Search for other works by this author on:
Stephane Sidobre,
Stephane Sidobre
3La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
Search for other works by this author on:
Mitchell Kronenberg,
Mitchell Kronenberg
3La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
Search for other works by this author on:
Paul B. Chapman
Paul B. Chapman
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021
2Swim Across America Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY 10021
Search for other works by this author on:
Dianna Y. Wu
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021
2Swim Across America Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY 10021
Neil H. Segal
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021
2Swim Across America Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY 10021
Stephane Sidobre
3La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
Mitchell Kronenberg
3La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
Paul B. Chapman
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021
2Swim Across America Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY 10021
Address correspondence to Paul B. Chapman, Dept. of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021. Phone: 212-639-5015; Fax: 212-794-4352; E-mail: [email protected]
The online version of this article includes supplemental material.
*
Abbreviations used in this paper: αGalCer, α-galactosylceramide; DN, double negative; NKT, natural killer T cell; TC, Tri-Color.
Received:
March 21 2003
Revision Received:
May 13 2003
Accepted:
May 14 2003
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2003
J Exp Med (2003) 198 (1): 173–181.
Article history
Received:
March 21 2003
Revision Received:
May 13 2003
Accepted:
May 14 2003
Citation
Dianna Y. Wu, Neil H. Segal, Stephane Sidobre, Mitchell Kronenberg, Paul B. Chapman; Cross-presentation of Disialoganglioside GD3 to Natural Killer T Cells . J Exp Med 7 July 2003; 198 (1): 173–181. doi: https://doi.org/10.1084/jem.20030446
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement